share_log

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $49

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $49

DA Davidson对Usana Health Sciences保持中立,将目标股价下调至49美元
Benzinga Real-time News ·  2022/10/27 16:51

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $57 to $49.

DA Davidson分析师琳达·博尔顿·韦瑟维持Usana Health Sciences(纽约证券交易所代码:USNA)为中性,并将目标股价从57美元下调至49美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发